Himar Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.78 M
as on 25-12-2024
- Revenue 5216.67%
(FY 2020)
- Profit -699.99%
(FY 2020)
- Ebitda -649.25%
(FY 2020)
- Net Worth -9.93%
(FY 2020)
- Total Assets -18.56%
(FY 2020)
About Himar Specialty Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹8.78 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Puneet Raizada and Priyanka Raizada serve as directors at the Company.
- CIN/LLPIN
U24200MH1997PTC111774
- Company No.
111774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 1997
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Himar Specialty Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Raizada  | Director | 15-Dec-2007 | Current |
| Priyanka Raizada | Director | 15-Dec-2007 | Current |
Financial Performance of Himar Specialty Chemicals.
Himar Specialty Chemicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 5216.67% increase. The company also saw a substantial fall in profitability, with a 699.99% decrease in profit. The company's net worth dipped by a decrease of 9.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Himar Specialty Chemicals?
In 2020, Himar Specialty Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Puneet Laboratories Private LimitedActive 38 years 2 monthsPuneet Raizada and Priyanka Raizada are mutual person
Supriya Bio-Tech Private LimitedActive 23 years 3 monthsPuneet Raizada and Priyanka Raizada are mutual person
- Innomac Healthcare Equipments Private LimitedActive 21 years 4 months
Puneet Raizada and Priyanka Raizada are mutual person
- Optimum Thrive Platforms Private LimitedActive 1 year 8 months
Puneet Raizada and Priyanka Raizada are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Shamrao Vithal Co-Op. Bank Ltd. Creation Date: 27 Jun 2009 | ₹3.50 M | Satisfied |
The Hongkong And Sanghai Banking Corporation Creation Date: 31 Jan 2008 | ₹4.68 M | Satisfied |
Corporation Bank Creation Date: 17 May 2002 | ₹0.60 M | Satisfied |
How Many Employees Work at Himar Specialty Chemicals?
Unlock and access historical data on people associated with Himar Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Himar Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himar Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
